Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil Iandra Holzmann, Cristiane V. Tovo, Roseline Minmé, Mônica P. Leal, Michele P. Kliemann, Camila Ubirajara, Amanda A. Aquino, Bruna Araujo, Paulo R.L. Almeida

Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study Gustavo H. Pereira, Helena R. Peixoto, Mariana L. Giusti, Mariana L. Souza, Livia B. Victor, Flávia Fernandes, Renata M. Perez, Cristiane A. Villela-Nogueira

Thyroid dysfunction in Turkish patients with chronic hepatitis C receiving peginterferon plus ribavirin in the period of 2005-2010 Sener Barut, Ozgur Gunal, Unal Erkorkmaz, Feyza Yildiz